Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trialJun Tian, Ryan B. Corcoran, Princy Sindurakar et al.|Nature Medicine|2023Cited by 197
SO-26 Clinical efficacy of combined BRAF, MEK, and PD-1 inhibition in BRAFV600E colorectal cancer patientsRyan B. Corcoran, Aparna R. Parikh, Marios Giannakis et al.|Annals of Oncology|2020Cited by 43
Diagnostic accuracy of point-of-care ultrasound with artificial intelligence-assisted assessment of left ventricular ejection fractionPouya Motazedian, Benjamin Hibbert, Jeffrey A. Marbach et al.|npj Digital Medicine|2023Cited by 36
Point-Of-Care Ultrasound with Artificial Intelligence-Assisted Assessment of Left Ventricular Ejection Fraction: A Prospective, Observational Multicentre StudyPouya Motazedian, Benjamin Hibbert, Jeffrey A. Marbach et al.|SSRN Electronic Journal|2022Cited by 0